Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1975 1
1976 1
1977 1
1981 1
2001 1
2005 1
2007 2
2010 1
2011 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Toxic alopecia from ingestion of boric acid.
Stein KM, Odom RB, Justice GR, Martin GC. Stein KM, et al. Among authors: justice gr. Arch Dermatol. 1973 Jul;108(1):95-7. Arch Dermatol. 1973. PMID: 4716745 No abstract available.
Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin's lymphoma.
Tulpule A, Rarick MU, Kolitz J, Bernstein J, Myers A, Buchanan LA, Espina BM, Traynor A, Letzer J, Justice GR, McDonald D, Roberts L, Boswell W, Nathwani B, Levine AM. Tulpule A, et al. Among authors: justice gr. Ann Oncol. 2001 Apr;12(4):457-62. doi: 10.1023/a:1011181016401. Ann Oncol. 2001. PMID: 11398876 Free article. Clinical Trial.
Leucovorin in combination chemotherapy of breast cancer.
Corder MP, Sheets RF, Stone WH, Flannery EP, Justice GR, Herbst KD. Corder MP, et al. Among authors: justice gr. Clin Pharmacol Ther. 1977 Apr;21(4):464-9. doi: 10.1002/cpt1977214464. Clin Pharmacol Ther. 1977. PMID: 300314
Efficacy and tolerability of transdermal granisetron for the control of chemotherapy-induced nausea and vomiting associated with moderately and highly emetogenic multi-day chemotherapy: a randomized, double-blind, phase III study.
Boccia RV, Gordan LN, Clark G, Howell JD, Grunberg SM; Sancuso Study Group. Boccia RV, et al. Support Care Cancer. 2011 Oct;19(10):1609-17. doi: 10.1007/s00520-010-0990-y. Epub 2010 Sep 12. Support Care Cancer. 2011. PMID: 20835873 Free PMC article. Clinical Trial.